Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jon Jureidini

Showing results (21-30 of 69) with videos related to

Pageof 7
Sort By:
The Journal of Clinical Psychiatry|August 7, 2008
Does venlafaxine maintenance therapy prevent depression recurrences or drug discontinuation reactions?Jon Jureidini, Barbara Mintzes
The British Journal of Psychiatry : the Journal of Mental Science|October 4, 2005
Wishful thinking: antidepressant drugs in childhood depressionAnne Tonkin, Jon Jureidini
The American Journal of Psychiatry|November 5, 2008
Should paroxetine be used to treat depression during pregnancy?Barbara Mintzes, Jon Jureidini
Lancet (London, England)|January 24, 2012
Novel melatonin-based treatments for major depressionJon Jureidini, Melissa Raven
The International Journal of Risk & Safety in Medicine|November 1, 2021
Barriers to access to clinical trial data: Obstruction of a RIAT reanalysis of the treatment for adolescents with depression studyNatalie Aboustate, Jon Jureidini
The Australian and New Zealand Journal of Psychiatry|October 3, 2012
Healthy Kids Check: lack of transparency and misplaced faith in the benefits of screeningJon Jureidini, Melissa Raven
Australian Family Physician|December 24, 2013
Psychosis. ReplyHsu-en Lee, Jon Jureidini
Australian Family Physician|September 12, 2013
Emerging psychosis in adolescents--a practical guideHsu-en Lee, Jon Jureidini
BMJ (Clinical Research Ed.)|March 17, 2022
The illusion of evidence based medicineJon Jureidini, Leemon B McHenry
Australasian Psychiatry : Bulletin of Royal Australian and New Zealand College of Psychiatrists|November 30, 2018
Doubling: a model for international clinical partnershipsJon Jureidini, Julie Stone, Molly Jureidini
Pageof 7

Showing results (21-30 of 69) with videos related to

Sort By:
Pageof 7
The Journal of Clinical Psychiatry|August 7, 2008
Does venlafaxine maintenance therapy prevent depression recurrences or drug discontinuation reactions?Jon Jureidini, Barbara Mintzes
The British Journal of Psychiatry : the Journal of Mental Science|October 4, 2005
Wishful thinking: antidepressant drugs in childhood depressionAnne Tonkin, Jon Jureidini
The American Journal of Psychiatry|November 5, 2008
Should paroxetine be used to treat depression during pregnancy?Barbara Mintzes, Jon Jureidini
Lancet (London, England)|January 24, 2012
Novel melatonin-based treatments for major depressionJon Jureidini, Melissa Raven
The International Journal of Risk & Safety in Medicine|November 1, 2021
Barriers to access to clinical trial data: Obstruction of a RIAT reanalysis of the treatment for adolescents with depression studyNatalie Aboustate, Jon Jureidini
The Australian and New Zealand Journal of Psychiatry|October 3, 2012
Healthy Kids Check: lack of transparency and misplaced faith in the benefits of screeningJon Jureidini, Melissa Raven
Australian Family Physician|December 24, 2013
Psychosis. ReplyHsu-en Lee, Jon Jureidini
Australian Family Physician|September 12, 2013
Emerging psychosis in adolescents--a practical guideHsu-en Lee, Jon Jureidini
BMJ (Clinical Research Ed.)|March 17, 2022
The illusion of evidence based medicineJon Jureidini, Leemon B McHenry
Australasian Psychiatry : Bulletin of Royal Australian and New Zealand College of Psychiatrists|November 30, 2018
Doubling: a model for international clinical partnershipsJon Jureidini, Julie Stone, Molly Jureidini
Pageof 7